Andrew Cittadine - Net Worth and Insider Trading

Andrew Cittadine Net Worth

The estimated net worth of Andrew Cittadine is at least $58,141 dollars as of 2024-06-03. Andrew Cittadine is the COO of Monopar Therapeutics Inc and owns about 93,624 shares of Monopar Therapeutics Inc (MNPR) stock worth over $58,141. Details can be seen in Andrew Cittadine's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Cittadine has not made any transactions after 2024-05-31 and currently still holds the listed stock(s).

Transaction Summary of Andrew Cittadine

To

Andrew Cittadine Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Cittadine owns 1 companies in total, including Monopar Therapeutics Inc (MNPR) .

Click here to see the complete history of Andrew Cittadine’s form 4 insider trades.

Insider Ownership Summary of Andrew Cittadine

Ticker Comapny Transaction Date Type of Owner
MNPR Monopar Therapeutics Inc 2024-05-31 Chief Operating Officer

Andrew Cittadine Latest Holdings Summary

Andrew Cittadine currently owns a total of 1 stock. Andrew Cittadine owns 93,624 shares of Monopar Therapeutics Inc (MNPR) as of May 31, 2024, with a value of $58,141.

Latest Holdings of Andrew Cittadine

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MNPR Monopar Therapeutics Inc 2024-05-31 93,624 0.62 58,141

Holding Weightings of Andrew Cittadine


Andrew Cittadine Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Cittadine has made a total of 2 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 36,000 shares on May 31, 2024, which cost Andrew Cittadine around $23,040.

Insider Trading History of Andrew Cittadine

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Cittadine Trading Performance

GuruFocus tracks the stock performance after each of Andrew Cittadine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Cittadine is 31.67%. GuruFocus also compares Andrew Cittadine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Cittadine within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew Cittadine's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew Cittadine

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew Cittadine Ownership Network

Ownership Network List of Andrew Cittadine

No Data

Ownership Network Relation of Andrew Cittadine

Insider Network Chart

Andrew Cittadine Owned Company Details

What does Monopar Therapeutics Inc do?

Who are the key executives at Monopar Therapeutics Inc?

Andrew Cittadine is the Chief Operating Officer of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Financial Officer Kim R Tsuchimoto , director & Chief Executive Officer Chandler Robinson , and other: Acting Chief Medical Officer Patrice Rioux .

Monopar Therapeutics Inc (MNPR) Insider Trades Summary

Over the past 18 months, Andrew Cittadine made 1 insider transaction in Monopar Therapeutics Inc (MNPR) with a net purchase of 36,000.

In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 36,000 shares, with a net purchase of 36,000 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 36,000 shares were bought by its insiders, resulting in a net purchase of 36,000 shares.

Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Monopar Therapeutics Inc Insider Transactions

No Available Data

Andrew Cittadine Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Cittadine. You might contact Andrew Cittadine via mailing address: C/o 1000 Skokie Blvd Suite 350, Wilmette Il 60091.

Discussions on Andrew Cittadine

No discussions yet.